Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,285.00    -10.00 (-0.44%)
Bid:
2,280.00
Ask:
2,285.00
Spread: 5.00 (0.219%)
Market Cap: £3.10b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

7 Feb 2023 07:00

RNS Number : 0825P
RIT Capital Partners PLC
07 February 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

7 February 2023

 

 

December 2022 Preliminary Unaudited Net Asset Value

 

The preliminary, unaudited, diluted net asset value of RIT Capital Partners plc (the Company) as at 31 December 2022 (with debt at fair value) was 2,388p per £1 ordinary share (30 November 2022: 2,454p).

This represented a decline of -2.7% for the month of December, outperforming the MSCI ACWI (50% £) which fell -5.0% in the month. The outperformance was driven by our quoted equity book, and positive contributions from both our absolute return & credit book as well as real assets. The NAV reflected the six-monthly revaluation of our direct private investments to 31 December 2022, and, as normal, the 30 September valuations from external managers for ~94% of our private funds (with around 6% at 31 December).

 

2022 Preliminary Unaudited Performance

 

Last year was one of the most challenging years for financial markets for more than a decade, with a multitude of issues causing almost all asset classes to decline during the year. The S&P 500, the NASDAQ and the FTSE 250 closed down -18%, -32% and -17% respectively. Government bonds provided no safe harbour, with long-term US and UK bonds losing -29% and -40% respectively. Our NAV was not immune from these pressures, with a preliminary, unaudited NAV per share total return (including dividends) of -13.3% compared to the ACWI of -12.9%. With inflation at multi-year highs, our inflation measure of CPI+3.0%, was 13.5% for the year. 

Key factors impacting our return for the year were:

-

Retaining one of our lowest quoted equity exposures in a decade, coupled with action we took within the quoted equity portfolio, helped limit the downside. Nevertheless, this book saw a negative contribution of around -6.7%;

-

Private investments detracted by -6.2% of NAV, split broadly equally across the directs and funds, giving back a portion of the ~+34% NAV contribution across 2020 and 2021;

-

Our absolute return and credit book held up reasonably well, albeit with some mixed performance from our macro managers;

-

Through our currency positioning, we ensured that much of our exposure was held outside the weakening sterling, resulting in a positive contribution for the year.

While any short-term decline in NAV is uncomfortable, our aims and objectives are long term. Over the last three years our NAV returned a preliminary ~25% against the ACWI at 17.7%. Similarly, our 5-year performance of around 41% compares favourably to the ACWI at 35.5%, and over 10-years our NAV (including dividends) has grown by approximately 140%.

As normal at this stage of our year end, the preliminary NAV is an estimate and remains subject to adjustment and audit. Full details will be included in the 2022 Annual Report & Accounts, which is expected to be published at the end of February.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVVQLFBXLLBBBQ
Date   Source Headline
4th Feb 20217:00 amRNSNet Asset Value(s)
23rd Dec 20207:00 amRNSTransaction in Own Shares
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.